USA - NYSE:MDT - IE00BTN1Y115 - Common Stock
The current stock price of MDT is 90.7 USD. In the past month the price decreased by -7.16%. In the past year, price increased by 0.7%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.77 | 215.16B | ||
| ISRG | INTUITIVE SURGICAL INC | 62.05 | 191.53B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.14 | 149.24B | ||
| SYK | STRYKER CORP | 27.05 | 136.19B | ||
| BDX | BECTON DICKINSON AND CO | 12.52 | 51.22B | ||
| IDXX | IDEXX LABORATORIES INC | 52.42 | 50.36B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.08 | 48.41B | ||
| RMD | RESMED INC | 24.94 | 36.03B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.33 | 34.22B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.46 | 26.31B | ||
| STE | STERIS PLC | 24.71 | 23.21B | ||
| DXCM | DEXCOM INC | 31.3 | 22.83B |
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
MEDTRONIC PLC
Building Two Parkmore Business Park West
DUBLIN DUBLIN D02 IE
CEO: Geoffrey S. Martha
Employees: 95000
Phone: 1135314381700
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
The current stock price of MDT is 90.7 USD. The price decreased by -0.3% in the last trading session.
MEDTRONIC PLC (MDT) has a dividend yield of 3.12%. The yearly dividend amount is currently 2.77.
MDT has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
MDT stock is listed on the New York Stock Exchange, Inc. exchange.
MEDTRONIC PLC (MDT) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
The next ex-dividend date for MEDTRONIC PLC (MDT) is September 26, 2025.
ChartMill assigns a technical rating of 1 / 10 to MDT. When comparing the yearly performance of all stocks, MDT turns out to be only a medium performer in the overall market: it outperformed 40.34% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to MDT. While MDT has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months MDT reported a non-GAAP Earnings per Share(EPS) of 5.53. The EPS increased by 5.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.63% | ||
| ROA | 5.12% | ||
| ROE | 9.73% | ||
| Debt/Equity | 0.55 |
39 analysts have analysed MDT and the average price target is 103.01 USD. This implies a price increase of 13.57% is expected in the next year compared to the current price of 90.7.
For the next year, analysts expect an EPS growth of 3.31% and a revenue growth 7.02% for MDT